Key terms

About CNMD

CONMED Corp. is a medical technology company, which engages in providing devices and equipment for surgical procedures. Its products include AirSeal and insufflation, allograft cartilage and tissue, arthroplasty, biliary and endoscopic ultrasound, biomedical sensors and electrodes, biopsy and polypectomy, dilators and accessories, electrosurgical units, fixation devices, hemostasis, implants and suture anchors, infection prevention, patient positioning, and related products. The company was founded by Eugene R. Corasanti in 1970 and is headquartered in Largo, FL.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest CNMD news

Feb 21 7:25am ET BTIG medical technology analyst to hold analyst/industry conference call Feb 21 4:55am ET BTIG medical technology analyst to hold analyst/industry conference call Feb 15 12:57pm ET BTIG medical technology analyst to hold analyst/industry conference call Feb 01 10:00am ET Conmed falls -12.3% Feb 01 9:47am ET Conmed falls -12.2% Feb 01 8:56am ET Conmed price target lowered to $100 from $130 at Piper Sandler Feb 01 8:21am ET Conmed price target lowered to $110 from $120 at Stifel Feb 01 8:10am ET Analysts Offer Insights on Healthcare Companies: Conmed (CNMD), Thermo Fisher (TMO) and Align Tech (ALGN) Feb 01 8:07am ET Piper Sandler Reaffirms Their Buy Rating on Conmed (CNMD) Feb 01 7:16am ET Conmed Performance Review: Hold Rating with Cautious Growth and Margin Outlook Feb 01 7:10am ET Conmed price target lowered to $98 from $107 at Wells Fargo Feb 01 6:41am ET Analysts Offer Insights on Healthcare Companies: Conmed (CNMD), Roche Holding AG (OtherRHHVF) and Sanofi (OtherSNYNF) Jan 31 4:10pm ET Conmed sees FY24 adjusted EPS $4.30-$4.40, consensus $4.40 Jan 31 4:09pm ET Conmed reports Q4 adjusted EPS $1.06, consensus $1.11 Jan 25 5:47am ET Hold Rating on Conmed Amid Competitive Pressures and Growth Uncertainties Jan 05 8:00am ET Analysts Are Bullish on These Healthcare Stocks: Conmed (CNMD), Illumina (ILMN) Dec 13 7:57am ET Wells Fargo Remains a Hold on Conmed (CNMD)

No recent press releases are available for CNMD

CNMD Financials

1-year income & revenue

Key terms

CNMD Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

CNMD Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms